Marshall N. Streeter, Ph.D., Manager, Technical Services - Cattle.
Summary
Aureomycin®, Bovatec®, Gainpro® and Rumensin®, four
medicated feed additives approved for use in cattle
grazing pasture and rangeland, were included in
digestible fiber based supplements at optimal levels to
compare their effects on cattle health and performance.
Difference in cattle performance were not detected
(P > 0.20) in the small (4 acre) improved forage
pastures grown under center-pivot irrigation in the
sandhill area of Nebraska. Foot rot was noted in all
treatment groups (Bovatec = 4; Gainpro = 2;
Rumensin = 1) except those receiving Aureomycin;
however, differences among treatment groups were not
significant. Likewise, differences in cattle performance
and health were not detected (P > 0.10) in the large
(140 - 160 acre) short grass native range pastures used
in eastern Colorado. Large pastures appear to amplify
supplement consumption differences among treatment
groups. Steers in eastern Colorado consumed more of
supplements containing Aureomycin, Bovatec, or
Gainpro than the supplement containing Rumensin.
Additional beneficial characteristics of individual
medicated feed additive products must be considered
when selecting a feed additive for use in a pasture
supplementation program and not just the magnitude of
growth response.
Introduction
Medicated feed additives are widely used in
supplements provided to yearling cattle grazing pasture
and rangeland to improve the efficiency of forage
resource utilization, enhance cattle performance,
improve cattle health and ultimately improve
profitability of cattle grazing operations. Four
medicated feed additives, two ionophores (Bovatec and
Rumensin) and two antibiotic medicated feed additives
(Aureomycin and Gainpro) have approvals that allow
their use in grazing situations. However, comparisons of
the health and performance benefits from all medicated
feed additives have not been conducted. The objective
of these experiments was to evaluate the efficacy of
ionophores and antibiotic medicated feed additives on
growth and health of stocker cattle grazing high quality
improved pasture and variable quality native rangeland.
Experimental Methods
Two studies were conducted to evaluate the
performance and health of yearling heifers and steers
supplemented with commercial supplements containing
one of the four approved medicated feed additives that
can be used in cattle grazing pastures and rangeland.
Common treatments of 350 mg of Aureomycin, 200 mg
of Bovatec, 20 mg of Gainpro and 200 mg of Rumensin
per head per day were formulated into commercially
produced pelleted digestible fiber based supplements
designed to complement forage conditions at each
locations. One study was conducted in the sandhill area
of north central Nebraska using small pastures
composed of improved forage species under a center-
pivot irrigation system. The other study was conducted
in large pastures located in eastern Colorado composed
of native cool and worm season forage species.
The Nebraska location used 160 yearling, British
crossbred spayed heifers (avg. initial wt. 556 lb),
randomly allotted to one of four treatment groups.
Heifers were placed into groups consisting of eight
animals/group with each treatment replicated in five
paddocks. Heifers grazed 4 acre pastures consisting of
improved mixed-species cool season grasses (7.7%
birdfoot trefoil, 7.7% Garrison creeping foxtail, 23%
Oathe intermediate wheat grass, 30.8% smooth
bromegrass, 30.8% Sterling orchard grass) which were
grown under center-pivot irrigation. Nutrient analysis of
clipped forage samples confirmed that forage remained
in good to excellent quality throughout the 99 day
summer grazing season (early June until early
September).
All supplements were group fed daily to provide one
pound of supplement per head per day. Ingredient
composition and calculated nutrient content of the
supplement is shown in Table 2. Samples from each
supplement were analyzed for respective medicated
feed additives to insure that additives were present at
formulation levels. Heifers also received 4 oz/hd/day of
mineral supplement fed with the daily concentrate
supplement resulting in a total supplement intake of
1.25 lb/hd/day. During the final three weeks of the
study, an additional one lb/hd/d of non-medicated
supplement was provided to insure adequate forage
availability and maintain a desired growth rate in the
cattle.
The Colorado location used 400 yearling steers
purchased from ranches in Nebraska and Oklahoma
with an average initial weight of 581 lb. Steers were
randomly allotted to treatment groups consisting of 100
animals. Cattle were place on pasture May 30 and 31
by randomly allotting cattle to specific pasture groups
consisting of 25 head each. Steers grazed short grass
native range pastures typical of the central and
southern Great Plains region that were approximately
140 to 160 acre in size. Native pastures consisted
primarily of blue grama, buffalograss, and western
wheat grass. Steers were rotated among four pastures
comprising a block at approximately two-week intervals
to reduce potential bias due to an individual pasture.
As typical of native rangeland, forage quality was high
at study initiation and declined as the 124 day summer
grazing season progressed. Interim body weight
measurements were not collected across all blocks.
All supplements were group fed daily to provide one
pound of supplement per head per day. Ingredient
composition and nutrient content of the supplement is
shown in Table 2. All medicated supplements were
manufactured and pelleted at a commercial feed mill as
one batch. Samples were collected for medicated feed
additive analysis to insure that supplements supplied
the correct amount of each additive. If the amount of
supplement in the feed bunks accumulated to an
excessive amount, it was removed and weighed.
Results
Body weight and growth rate data were analyzed from
the Nebraska study site as a completely randomized
design and from the Colorado site as a randomized
block disign. Initial and final weight data from both
locations are shown in Table 3. Medicated feed additive
treatment did not affect interim weight (P > 0.90) at the
Nebraska location or final weight (P > 0.10) at either
study location.
Average daily gain measurements from the Nebraska
and Colorado study locations are shown in Figure 1.
Difference in average daily gain (ADG) resulting from
medicated feed additive treatments, were not observed
in the small improved pastures at the Nebraska site
(P > 0.20) or the large short grass native range pastures
at the Colorado site (P > 0.10).
During both studies cattle were observed on a daily
basis for health problems such as bovine respiratory
disease, anaplasomsis, coccidiosis and foot rot. Neither
location noted significant incidence of bovine
respiratory disease (Nebraska site noted 0 BRD;
Colorado site noted one death from chronic
pneumonia), anaplasmosis or coccidiosis. At the
Nebraska location, heifers were treated for foot rot in
the Bovatec (4), Gainpro (2), and Rumensin (1)
treatment but not in the Aureomycin treatment group.
The large pastures used in Colorado resulted in the need
to weigh unconsumed supplement; whereas, the heifers
in the small pastures in Nebraska completely consumed
their supplement each day. This effect is likely the result
of differences pasture size rather than forage condition
difference at the two locations. In small pasture
environments cattle tend to socialize around water and
supplement feeding locations often in close proximity to
each other. However, in less densely populated large
pasture environments supplement location may be
further from water in an attempt to redistribute grazing
pressures. In large pastures at the Colorado location,
steers consumed more supplement containing
Aureomycin (0.85 lb/d), Bovatec (0.92 lb/d) and Gainpro
(0.86 lb/d) than supplement containing Rumensin (0.69 lb/d).
Implications
The results of these studies demonstrate the challenges
of differentiating medicated feed additives approved for
use in grazing cattle on the basis of animal
performance. Study sites used to evaluate medicated
feed additive program represent the extreme variation
in pasture and range conditions typical of summer
grazing programs in the Great Plains region. Regardless
of forage quality, forage availability and stocking
density, differences in cattle performance were not
noted among medicated feed additive programs.
Additional beneficial characteristics of individual
medicated feed additives, such as control of bovine
respiratory, control of anaplsmosis, and prevention and
control of coccidiosis, must be considered when
selecting a medicated feed additive for use in pasture
supplementation conditions.
Aureomycin is a registered trademark of Alpharma Inc.
Bovatec is a registered trademark of Alpharma Inc.
USA Gainpro is a registerred trademark of Intervet.
Rumensin is a registered trademark of Elanco’s brand of monensin sodium.
© Copyright 2005 Alpharma Inc. All rights reserved.
Alpharma Inc.
One Executive Drive
Fort Lee, NJ 07024
1-800-643-5791
Technical Bulletin no: CD0491